Clinical trial
Radiolabeled Monoclonal Antibody Plus Peripheral Stem Cell Transplantation in…
NCT00004177 · Garden State Cancer Center at the Center for Molecular Medicine and Immunology, Other · Completed
Key facts
| NCT number | NCT00004177 |
|---|---|
| Title | Radiolabeled Monoclonal Antibody Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory or Recurrent Ovarian Epithelial Cancer |
| Official title | Phase I/II Radioimmunotherapy With High-Dose 90Y-Labeled Humanized MN-14 in Advanced Ovarian Cancer Using Autologous Peripheral Blood Stem Cell Rescue (PBSCR) to Control Myelotoxicity |
| Lead sponsor | Garden State Cancer Center at the Center for Molecular Medicine and Immunology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Ovarian Cancer |
| Intervention type | Biological, Procedure, Radiation |
| Interventions | filgrastim, peripheral blood stem cell transplantation, indium In 111 monoclonal antibody MN-14, yttrium Y 90 monoclonal antibody MN-14 |
| Enrollment | 15 |
| Start date | Aug 1, 1999 |
| Primary completion | May 1, 2002 |
| First posted | Apr 16, 2004 |
| Last update posted | Jun 22, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: